Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

It has the most potent weight-loss shot and a large experimental pipeline, including what is widely expected to be the first ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...

Tirzepatide injection (Zepbound, Mounjaro) is officially off the FDA's drug shortage list, meaning compounders can no longer prepare and dispense the drug.

Momentum investing is based on the idea that stocks that have risen recently will tend to keep rising and that stocks that ...

While there's some ambiguity about the term "next generation" when it comes to weight loss therapies, one thing is clear: ...

Turkey's Huzur Devletsah is the first woman to head Eli Lilly's China affiliate since the U.S. pharma maker began operations ...

The stupendous success of GLP-1 drugs, Mounjaro (diabetes) and Zepbound (obesity), has made it the largest drugmaker with a ...

We recently compiled a list of the 8 Best Momentum Stocks To Invest In Right Now. In this article, we are going to take a ...

GLP-1 drugs are being recommended on social media, raising questions about who can see the content and what the effects might ...

After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...